← Chris Bloomstran, latest 13F
Chris Bloomstran · Q1 2015
Semper Augustus Investments
Portfolio at the end of Q1 2015, from the 13F filed May 14, 2015. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Berkshire Hathaway BRK.B · history | 18.5% | Q2 2013 or earlier | No change |
| Exxon Mobil XOM · history | 14.1% | Q2 2013 or earlier | No change |
| Berkshire Hathaway BRK.A · history | 12.2% | Q2 2013 or earlier | No change |
| Mercury General MCY · history | 7.5% | Q2 2013 or earlier | No change |
| Goldcorp GG · history | 5.9% | Q2 2013 or earlier | No change |
| Jefferies Financial Group JEF · history | 4.5% | Q2 2013 or earlier | No change |
| WaFd WAFD · history | 3.4% | Q2 2013 or earlier | No change |
| Merck MRK · history | 3.0% | Q2 2013 or earlier | Reduce 8% |
| Sanofi SNY · history | 2.8% | Q2 2013 or earlier | No change |
| Intel INTC · history | 2.5% | Q2 2013 or earlier | No change |
| General Electric GE · history | 2.4% | Q2 2013 or earlier | No change |
| Microsoft MSFT · history | 2.3% | Q2 2013 or earlier | Add 1% |
| AVX AVX · history | 2.0% | Q2 2013 or earlier | No change |
| Costco COST · history | 2.0% | Q2 2013 or earlier | No change |
| Validus Holdings VR · history | 1.6% | Q2 2013 or earlier | No change |
| RB Global RBA · history | 1.5% | Q3 2013 | No change |
| Equinor EQNR · history | 1.5% | Q2 2013 or earlier | No change |
| Travelers TRV · history | 1.4% | Q2 2013 or earlier | No change |
| PepsiCo PEP · history | 1.4% | Q2 2013 or earlier | No change |
| Johnson & Johnson JNJ · history | 1.3% | Q2 2013 or earlier | Reduce 1% |
| Coca-Cola KO · history | 1.3% | Q2 2013 or earlier | No change |
| American Express AXP · history | 1.2% | Q1 2015 | Buy |
| Newmont NEM · history | 1.2% | Q2 2013 or earlier | No change |
| Chicago Bridge & Iron CBI · history | 1.1% | Q3 2014 | No change |
| CNA Financial CNA · history | 1.0% | Q2 2013 or earlier | No change |
| Kinross Gold KGC · history | 0.8% | Q2 2013 or earlier | No change |
| Chubb CB · history | 0.7% | Q2 2013 or earlier | No change |
| Medtronic MDT · history | 0.3% | Q2 2013 or earlier | No change |
| Vical VICL · history | 0.2% | Q2 2013 or earlier | No change |
| Shell RDS.A · history | 0.2% | Q2 2013 or earlier | No change |
| DST Systems DST · history | 0.2% | Q1 2015 | Buy |
| 31 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q4 2014, adjusted for stock splits.
Sector weighting
| Financials & real estate | 52.0% | |
|---|---|---|
| Energy | 15.8% | |
| Materials | 7.8% | |
| Health care | 7.6% | |
| Technology | 7.0% | |
| Industrials | 5.0% | |
| Consumer staples | 4.7% |
What changed from Q4 2014
- Buy American Express AXP 1.2% of the 13F
- Buy DST Systems DST 0.2% of the 13F
- Add 1% Microsoft MSFT 2.5% → 2.3%
- Reduce 8% Merck MRK 3.1% → 3.0%
- Reduce 1% Johnson & Johnson JNJ 1.4% → 1.3%
- Sell Ampio Pharmaceuticals AMPE was 0.0%